Jubilant Cadista Pharmaceuticals, Inc. recalls Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., S

Recalled June 3, 2020 · FDA recall D-1281-2020 · Jubilant Cadista Pharmaceuticals

Hazard

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product. · FDA Class III

Units

1,313,333 tablets

Sold at

Description

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Product

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

Manufacturer(s)

Jubilant Cadista Pharmaceuticals, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →